Moderate or severe valvular heart disease and outcomes in allogeneic stem cell transplantation
- 1 October 2019
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 292, 166-170
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL099993, HL088021)
This publication has 8 references indexed in Scilit:
- Recommendations for Noninvasive Evaluation of Native Valvular RegurgitationJournal of the American Society of Echocardiography, 2017
- 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: Executive SummaryJACC, 2014
- 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac SurgeryJACC, 2014
- 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart DiseaseJACC, 2014
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTBlood, 2005
- Quantitative Determinants of the Outcome of Asymptomatic Mitral RegurgitationNew England Journal of Medicine, 2005
- Impact of tricuspid regurgitation on long-term survivalJACC, 2004
- Mild and moderate aortic stenosis Natural history and risk stratification by echocardiographyEuropean Heart Journal, 2004